FGEN—My guess is that the dataset reported today is less impressive than the earlier dataset from the same trial reported at ASCO in 2022. I don’t follow the company closely.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.